Oorsprong van het eerstegraads netwerk van Amalia Schmidt
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
IMD Natural Solutions GmbH
 IMD Natural Solutions GmbH Food RetailRetail Trade IMD Natural Solutions GmbH develops preservative agents. Its product, INS Glycolipid, is a natural mushroom extract that is water soluble and can be used for preservation applications. The company was founded in 2012 and is headquartered in Dortmund, Germany.
2
| Subsidiary | Food Retail | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Amalia Schmidt via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Gottingen | College/University | Doctorate Degree | |
S Direkt-Marketing GmbH & Co. KG
 S Direkt-Marketing GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Part of Saalesparkasse, S Direkt-Marketing GmbH & Co. KG is a German company that specializes in telephone campaigns for product sales and efficient outbound campaigns for savings banks. The company is based in Halle, Germany. The company also design new platform offers and provide IT infrastructure, design interfaces to cooperation partners and content, and make fintech applications usable for savings banks. The CEOs of the company are Thomas Henkel, Ingo van Uehm. S Direkt-Marketing offers holistic solutions from a single source for savings banks and network partners, including media customer services, innovative added value, and new digital services. The company offers attractive positions for modern challenges. | Miscellaneous Commercial Services | Chief Executive Officer | |
TARGOS Molecular Pathology GmbH
 TARGOS Molecular Pathology GmbH BiotechnologyHealth Technology Part of Discovery Life Sciences LLC, TARGOS Molecular Pathology GmbH is a German company that provides biomarker services. The company is based in Kassel, Germany. The company was founded in 2005 by Reinhard Büttner, Josef Rüschoff, Thomas Henkel. Thomas Henkel has been the CEO since 2005. TARGOS Molecular Pathology was acquired by Discovery Life Sciences LLC on May 18, 2021. | Biotechnology | Chief Executive Officer |
Statistieken
Internationaal
| Duitsland | 7 |
Sectoraal
| Health Technology | 4 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Operationeel
| Chief Executive Officer | 4 |
| Corporate Officer/Principal | 3 |
| Founder | 2 |
| President | 1 |
| Doctorate Degree | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Thomas Henkel | 7 |
| Ingo Broda | 1 |
- Beurs
- Insiders
- Amalia Schmidt
- Bedrijfsconnecties
